Delivery Order SPE2DB20D7059-SPE2DB24FPTV2
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Moderna COVID-19 vaccines for ages 6 months to 11 years old under an Emergency Use Authorization (EUA). The contract is a $4,752.75 firm fixed-price delivery order with an ultimate completion date of April 8, 2025. The contract is not a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $1,476.88 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which serves as the primary supplier of pharmaceutical and medical products to the Department of Defense (DoD) and other government agencies. This...
- This federal contract award, with ID SPE2DB22D2007|SPE2DB25FH8CY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,290.00 firm fixed-price delivery order is for the procurement of Moderna COVID-19 vaccine doses for individuals aged 6 months to 11 years, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of Moderna COVID-19 vaccines for individuals aged 6 months to 11 years under the Emergency Use Authorization (EUA). The contract, valued at $1,290.00, is a firm fixed-price delivery order contract with a completion date of March 12, 2025. The contract does not have a set-aside designation. Amerisourcebergen...
- This federal contract award, valued at $2,215.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor to the U.S. government. The contract is for the delivery of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, has an award value of $1,272.22 and is for the delivery of 0.25 ml doses of the Moderna COVID-19 vaccine to support the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The contract is a Delivery Order under a Firm Fixed Price arrangement and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. This award is not a set-aside contract. The contract has an ultimate...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The $2,215.32 firm-fixed-price contract is a delivery order without a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will provide the 0.25 mL vaccine doses to support the DLA's mission of supplying medical commodities to the...
- This is a $1,290 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Moderna COVID-19 vaccines for the 6-month to 11-year-old age group under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 27, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award, with ID SPE2DB20D6035|SPE2DB25FLXNS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Moderna COVID-19 vaccines for individuals ages 6 months to 11 years under the Emergency Use Authorization (EUA). The contract has a ceiling value of $1,290.00 and is a firm fixed-price delivery order with a completion date of February 13, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
- This federal contract award, valued at $4,556.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of Moderna COVID-19 vaccine doses for the 6-month to 11-year-old age group under an Emergency Use Authorization (EUA). Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through 2025....
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FPTV2Delivery Order
This federal contract award, ID SPE2DB20D7059, is a delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of Moderna COVID-19 vaccines in the 6-month to 11-year age group under the Emergency Use Authorization (EUA). The $3,797.30 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on November 1, 2023, with a completion date of November 24, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/1/23 |